Adaptive immune gene signatures correlate with response to flotetuzumab, a CD123 × CD3 bispecific Dart® molecule, in patients with relapsed/refractory acute myeloid leukemia

Rutella, S ORCID: https://orcid.org/0000-0003-1970-7375, Church, SE, Vadakekolathu, J ORCID: https://orcid.org/0000-0002-2671-4285, Viboch, E, Sullivan, AH, Hood, T, Warren, SE, Cesano, A, La Motte-Mohs, R, Muth, J, Lelièvre, H, Lowenberg, B, DiPersio, JF and Davidson-Moncada, JK, 2018. Adaptive immune gene signatures correlate with response to flotetuzumab, a CD123 × CD3 bispecific Dart® molecule, in patients with relapsed/refractory acute myeloid leukemia. Blood, 132 (S1): 444. ISSN 0006-4971

Full text not available from this repository.

Item Type:	Journal article
Publication Title:	Blood
Creators:	Rutella, S., Church, S.E., Vadakekolathu, J., Viboch, E., Sullivan, A.H., Hood, T., Warren, S.E., Cesano, A., La Motte-Mohs, R., Muth, J., Lelièvre, H., Lowenberg, B., DiPersio, J.F. and Davidson-Moncada, J.K.
Publisher:	American Society of Hematology
Date:	29 November 2018
Volume:	132
Number:	S1
ISSN:	0006-4971
Identifiers:	Number Type 10.1182/blood-2018-99-111539 DOI
Divisions:	Schools > School of Science and Technology
Record created by:	Linda Sullivan
Date Added:	19 Dec 2018 09:57
Last Modified:	04 Feb 2022 16:21
Related URLs:	Publisher
URI:	https://irep.ntu.ac.uk/id/eprint/35385

Actions (login required)

Edit View

Statistics

Views

Downloads